Abstract: The ebv have been made two clinical trials in neurooncology based 1-gene therapy 2-neurosurgery molecular PET since the ebv have been built 2 poweful phenomenons which are; tocagene self powered by c-group and self powered by p-group in a recommendatiotions of cis/trans helix loop helix phenomenon of cis/trans carboxyl group based helix loop helix by phosphate group trans in issue based p-group and cis in issue based c-group.
The nitrogenous base (A & G) fully forms the ebv gene seven in one to six ribosomes for a trans proteins subunit like phenylalanine and tyrosine based covalent and ionic bonds in its shape and a Brilliant form.
Keywords: ebv (Epstein Barr Virus); tocagen toca 511 and toca FC (5-fluorocytosine prodrug of 5-fluorouracil); P-group & C-group; brain tumors (GBM & MB); Molecular Imagings (MRI & PET).
Title: Clinical trial Phase - IV For Brain Tumors Based Nanodrugs Via Advanced Molecular Biology & Molecular Neurosurgery Levels a Theory Of gene Engineering Technology {{a clues For New Drug}}
Author: Ahmad Issa Ahmad Funjan
International Journal of Healthcare Sciences
ISSN 2348-5728 (Online)
Vol. 10, Issue 1, April 2022 - September 2022
Page No: 21-24
Research Publish Journals
Website: www.researchpublish.com
Published date: 10-May-2022
